CHEK2 and cancer: This pattern suggests that statins may partially inhibit cancer DNA repair mechanisms by altering the normal phosphorylation dynamics of key kinases such as CHEK2 and ATM (which also decreases their phosphorylation), thereby weakening the cellular response to DNA damage.